These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 77201)
21. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors. Chapes SK; Gooding LR J Immunol; 1985 Sep; 135(3):2192-8. PubMed ID: 2991384 [TBL] [Abstract][Full Text] [Related]
22. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity. Evans R; Alexander P Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104 [TBL] [Abstract][Full Text] [Related]
23. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes. Fidler IJ; Bucana C Cancer Res; 1977 Nov; 37(11):3945-56. PubMed ID: 908034 [TBL] [Abstract][Full Text] [Related]
24. Preferential generation of killer or helper T-lymphocyte activity directed to the tumour-associated transplantation antigens. Fujiwara H; Hamaoka T; Teshima K; Aoki H; Kitagawa M Immunology; 1976 Aug; 31(2):239-48. PubMed ID: 1085283 [TBL] [Abstract][Full Text] [Related]
25. Protection of mice against syngeneic C1300 neuroblastoma challenge by immunization with membranes of C1300 neuroblastoma cells. Lauro G; Businaro R; Butler RH; Revoltella R J Natl Cancer Inst; 1980 May; 64(5):1169-72. PubMed ID: 6929017 [TBL] [Abstract][Full Text] [Related]
26. The genetics of cytostasis [proceedings]. de Giorgi L; Biasi G; Festenstein H Folia Biol (Praha); 1976; 22(6):437-8. PubMed ID: 1001565 [No Abstract] [Full Text] [Related]
27. The role of H-2 and H-2-like determinants in syngeneic and allogeneic cytostasis. De Giorgi L; Biasi G; Festenstein H J Immunogenet; 1978 Feb; 5(1):49-57. PubMed ID: 76664 [TBL] [Abstract][Full Text] [Related]
28. Virus-dependent cytostatic activity to mammary tumor cells of lymphocytes from normal mice. Gillette RW; Lowery LT Cancer Res; 1976 Nov; 36(11 Pt 1):4008-14. PubMed ID: 184922 [TBL] [Abstract][Full Text] [Related]
29. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses. Lucas CJ; Levy RB; Shearer GM J Immunol; 1981 Apr; 126(4):1255-9. PubMed ID: 6970767 [TBL] [Abstract][Full Text] [Related]
30. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages. Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520 [TBL] [Abstract][Full Text] [Related]
31. Detection of tumour-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumour-free syngeneic mice. 3. Demonstration of this antigen on the lymphoreticular system of adult mice. Rejthar A; Wotke J Folia Biol (Praha); 1974; 20(4):244-51. PubMed ID: 4472054 [No Abstract] [Full Text] [Related]
32. Role of cytostasis in antitumor immunity against syngeneic X5563 plasmocytoma: comparative study of cytostasis and cytolysis using variant tumors and neonatally thymectomized mice. Mitani M; Himeno K; Mori K; Nomoto K J Clin Lab Immunol; 1989 May; 29(1):45-52. PubMed ID: 2628584 [TBL] [Abstract][Full Text] [Related]
33. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells. Ohnishi K; Bonavida B J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977 [TBL] [Abstract][Full Text] [Related]
34. Soluble suppressor of T cell proliferation in primary in vitro response to murine minor histocompatibility antigens. Solana R; Alonso MC; de la Fuente M; Alonso A; Peña J Rev Esp Fisiol; 1984 Sep; 40(3):341-52. PubMed ID: 6240742 [TBL] [Abstract][Full Text] [Related]
35. Role of H-2 antigens in the cytolysis of Oncornavirus induced tumour cells by syngeneic T lymphocytes [proceedings]. Gomard E; Duprez V; Henin Y; Levy JP Folia Biol (Praha); 1976; 22(6):387-8. PubMed ID: 1087248 [No Abstract] [Full Text] [Related]
36. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved. Cihak J; Ziegler HW; Kölsch E Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346 [TBL] [Abstract][Full Text] [Related]
37. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo. Lake P; Sabbadini E; Sehon AH Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936 [TBL] [Abstract][Full Text] [Related]
38. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro. Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374 [TBL] [Abstract][Full Text] [Related]
39. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response. Gordon WC; Prager MD Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275 [TBL] [Abstract][Full Text] [Related]
40. The role of autosensibilization of lymphoid cells in genesis of antitumor resistance. Malygin AM; Fel VJ Neoplasma; 1979; 26(4):429-37. PubMed ID: 522915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]